HomeOpen Access NewsPharmaceutical Industry

Pharmaceutical Industry

UK Government and CPE agree on record funding deal to expand pharmacy services

Patients will benefit from new pharmacy services, as the Government and Community Pharmacy England (CPE) agree on a £617m investment.

CND session of March 2020: Low THC products?

Here Kathleen Denoodt explains the role of ECDD and why she believes the recommendations of the investigative report should be followed.

The ‘why’ and ‘what’ of academic drug discovery research at the University of Strathclyde

Prof Colin J Suckling OBE DSc FRSE from the Department of Pure & Applied Chemistry, details the ‘why’ and ‘what’ of academic drug discovery research at the University of Strathclyde, as well as his thoughts on the value of a chemistry degree.

Addressing how cannabis businesses are banked: Room for improvement?

With attention turning in the U.S. and elsewhere to how cannabis businesses are banked, John Binns, Partner at BCL Solicitors LLP, gets into the weeds of how UK banks have been addressing the issue, as well as the prospects for improvement.

What is the Europe Canna Expo?

Kristina Spionjak discusses what will happen at Europe Canna Expo 2020, and reflects on opportunities for the medical cannabis industry.

A focus on the rise of cannabidiol (CBD)

George Thomas, Managing Director of Goodbody Botanicals, part of Sativa Group Plc, turn our thoughts towards the undoubted rise of cannabidiol (CBD).

What are the most common myths about CBD?

Here, Paul Segal, chairman and co-founder of Symtomax, details what the most common myths about CBD are.

Why is it so hard to determine which CBD products to buy?

Jade Mansfield from British CBD Company, explains why it is so hard to know which CBD products to buy since its growth in popularity.

Canada: Promoting social science and humanities research

Promoting social science and humanities research in universities and colleges across Canada is charted here by Open Access Government.

The pharmaceutical industry in Europe

Here, we focus on some of the key issues facing the pharmaceutical industry throughout Europe.

Medical use of cannabinoids and marijuana

In this article, Dr Gerry Morrow shares his thoughts on the medical use of cannabinoids and marijuana.

The medical cannabis market in Denmark & Europe

Investment Manager at the Ministry of Foreign Affairs of Denmark, Michael Prytz, charts the rapid development of the medical cannabis market in Europe and provides a look at the Danish model in this vein.

What next for the UK’s cannabis laws?

John Binns, Partner at BCL Solicitors LLP looks at the UK’s cannabis laws and how they could be improved.

From Cannabis flower to final products: Extractions for Phytopharmaceuticals

Dr Nikos Xynos, PhD in Pharmaceutical Sciences/Natural Products Chemistry and MD a Nomad Labs, explores the various pathways to cannabinoid extraction, refining and purification technologies.

Medicinal cannabis: What the UK can learn from Denmark

Spectrum Therapeutics UK lifts the lid here on a pilot analysis of medicinal cannabis use that will run in Denmark until January 2022.

SSPC: Training the next generation of highly skilled pharmaceutical scientists and engineers

Louise O’Neill from SSPC, the SFI Research Centre for Pharmaceuticals, underlines the importance of training the next generation of highly skilled pharmaceutical scientists and engineers in Ireland.

The value of accreditation in the cannabis industry

Chris Gunning, General Manager – Accreditation Services at A2LA, discusses the value of accreditation in today’s cannabis industry.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders